We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

70 hedge funds and large institutions have $16.7M invested in Spectrum Pharmaceuticals Inc in 2022 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 25 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

245% more call options, than puts

Call options by funds: $276K | Put options by funds: $80K

7% less funds holding

Funds holding: 7570 (-5)

26% less capital invested

Capital invested by funds: $22.7M → $16.7M (-$5.98M)

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

44% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 25

Holders
70
Holders Change
-5
Holders Change %
-6.67%
% of All Funds
1.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
14
Reduced
25
Closed
13
Calls
$276K
Puts
$80K
Net Calls
+$196K
Net Calls Change
+$76K
Name Holding Trade Value Shares
Change
Change in
Stake
Citigroup
76
Citigroup
New York
-$1K -2,064 Closed
CUAMC
77
China Universal Asset Management Company
China
-$1K -1,763 Closed
IA
78
IFP Advisors
Florida
-$6K -295 Closed
Royal Bank of Canada
79
Royal Bank of Canada
Ontario, Canada
+$7 +17 +2%

SPPI Hedge Fund Activity: Q4 2022 in Review

70 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q4 2022, worth a combined $16.7M — down 26% from $22.7M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of SPPI and 8 opened new positions — a net loss of 5 holders — while 25 trimmed existing stakes and 14 added.

The largest buyer was Acadian Asset Management, adding an estimated $1.01M. The largest seller was BlackRock, cutting an estimated $1.41M.

  • 70 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q4 2022, down from 75 in Q3 2022.
  • Funds reported $16.7M of Spectrum Pharmaceuticals Inc stock for Q4 2022, down 26% quarter-over-quarter.
  • 8 funds opened new Spectrum Pharmaceuticals Inc positions in Q4 2022 and 13 closed out, a net change of -5 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q4 2022 was Acadian Asset Management, an estimated $1.01M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q4 2022 was BlackRock, an estimated $1.41M sold.

Based on aggregated 13F filings for Q4 2022.